Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
David Moreno‐Delgado, Mar Puigdellívol, Estefanía Moreno, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101994-101994
Closed Access | Times Cited: 68
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Yifei Feng, Yan Lü
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Role of Dopamine in the Heart in Health and Disease
Joachim Neumann, Britt Hofmann, Stefan Dhein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5042-5042
Open Access | Times Cited: 32
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Sergi Ferré, Francisco Ciruela, Carmen Dessauer, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107977-107977
Open Access | Times Cited: 49
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 32
A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H3 Receptor
Niklas Rosier, Lukas Grätz, Hannes Schihada, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11695-11708
Closed Access | Times Cited: 33
Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder
Mera Alhusaini, Nermin Eissa, Ali Saad, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Computational Assessment of the Phytochemicals of Panax ginseng C.A. Meyer Against Dopamine Receptor D1 for Early Huntington’s Disease Prophylactics
Jhashanath Adhikari Subin, Ram Lal Shrestha
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3413-3423
Closed Access | Times Cited: 5
Dopamine D1 receptor agonist alleviates post-weaning isolation-induced neuroinflammation and depression-like behaviors in female mice
Ziwei Zhao, Ying Wang, Pei‐Chun Chen, et al.
Behavioral and Brain Functions (2025) Vol. 21, Iss. 1
Open Access
Regulation of membrane NMDA receptors by dynamics and protein interactions
Mar Petit‐Pedrol, Laurent Groc
The Journal of Cell Biology (2020) Vol. 220, Iss. 1
Open Access | Times Cited: 36
Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington’s Disease Mice Prior to Onset of Symptoms
Isaline Mees, Harvey Tran, Anne M. Roberts, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2456-2471
Closed Access | Times Cited: 19
The histamine H3 receptor modulates dopamine D2 receptor–dependent signaling pathways and mouse behaviors
Jian Xu, Christopher Pittenger
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104583-104583
Open Access | Times Cited: 11
G Protein–Coupled Receptor Heteromers in Brain: Functional and Therapeutic Importance in Neuropsychiatric Disorders
Yang Sun, Ahmed Hasbi, Susan R. George
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 215-236
Closed Access
Single-molecule localization microscopy as a tool to quantify di/oligomerization of receptor tyrosine kinases and G protein-coupled receptors
Katie L. Sharrocks, Aisha M. Swaih, Aylin C. Hanyaloglu
Molecular Pharmacology (2025) Vol. 107, Iss. 5, pp. 100033-100033
Open Access
Dopaminergic system and neurons: role in multiple neurological diseases
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 3
Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy
Aruna Sharma, Dafin F. Mureşanu, Ranjana Patnaik, et al.
Progress in brain research (2021), pp. e1-e2
Closed Access | Times Cited: 20
Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity
Meichun Gao, Jasper F. Ooms, Rob Leurs, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 761-761
Open Access | Times Cited: 2
Abnormally abrupt transitions from sleep-to-wake in Huntington’s disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics
Will T. Schneider, Szilvia Vas, Alister U. Nicol, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251767-e0251767
Open Access | Times Cited: 17
Histaminergic System Activity in the Central Nervous System: The Role in Neurodevelopmental and Neurodegenerative Disorders
Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9859-9859
Open Access | Times Cited: 1
In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases
Purusottam Banjare, Balaji Wamanrao Matore, Anjali Murmu, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 29, pp. 2765-2791
Closed Access | Times Cited: 3
Positron Emission Tomography (PET) Imaging Biomarkers in Huntington’s Disease
Liesbeth Everix, Steven Staelens, Daniele Bertoglio
Contemporary clinical neuroscience (2023), pp. 127-158
Closed Access | Times Cited: 3
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2
Federica Bono, Zaira Tomasoni, Veronica Mutti, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 473-473
Open Access | Times Cited: 2
IGF/mTORC1/S6 Signaling Is Potentiated and Prolonged by Acute Loading of Subtoxicological Manganese Ion
Xue-Qi Tang, Rekha C. Balachandran, Michael Aschner, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1229-1229
Open Access | Times Cited: 2
Neurodegenerative Diseases: New Hopes and Perspectives
Mohammad Aadil Bhat, Suneela Dhaneshwar
Current Molecular Medicine (2023) Vol. 24, Iss. 8, pp. 1004-1032
Closed Access | Times Cited: 2
New insights into the functional impact of G protein–coupled receptor oligomerization
Gillian P. Johnson, Uche Agwuegbo, Kim Jonas
Current Opinion in Endocrine and Metabolic Research (2020) Vol. 16, pp. 43-50
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top